Novel drug treatments for schizophrenia.
D000322:Adrenergic Agonists / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001058:Apomorphine / Q000627:therapeutic use; D001971:Bromocriptine / Q000627:therapeutic use; D006801:Humans; D009479:Neuropeptides / Q000627:therapeutic use; D011954:Receptors, Dopamine / Q000187:drug effects; D012559:Schizophrenia / Q000188:drug therapy*
D000322:Adrenergic Agonists; D014150:Antipsychotic Agents; D009479:Neuropeptides; D011954:Receptors, Dopamine; D001971:Bromocriptine; D001058:Apomorphine